BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  Dyax Corp. Announces Second Quarter 2012 Financial Results

  July 20, 2012

   · 

  1 min read
• BioForest

  Seattle Genetics, Inc. Announces ADCETRIS® Receives Positive CHMP Opinion for Conditional Approval in European Union

  July 20, 2012

   · 

  1 min read
• ICON Shareholders Vote in Favour of All Resolutions at Its Annual General Meeting

  July 20, 2012

   · 

  1 min read
• Business

  Quest Diagnostics Inc. Reports Second Quarter 2012 Financial Results

  July 20, 2012

   · 

  6 min read
• Business

  Sunshine Biopharma, Inc. Engages Beta Pharma Canada for Manufacturing of an Initial Batch of Adva-27a

  July 20, 2012

   · 

  1 min read
• Pharm Country

  Optimer Pharmaceuticals, Inc. to Ring the NASDAQ Stock Market Opening Bel

  July 20, 2012

   · 

  1 min read
• Business

  Gilead Sciences, Inc. to Release Second Quarter 2012 Financial Results on Thursday, July 26, 2012

  July 20, 2012

   · 

  1 min read
• Genetown

  Millennium: The Takeda Oncology Company and Takeda Pharmaceutical Co. Ltd. Announce Positive CHMP Opinion for Conditional Approval of ADCETRIS® (brentuximab vedotin) in Europe

  July 20, 2012

   · 

  1 min read
• Seattle Genetics, Inc. Announces ADCETRIS® Receives Positive CHMP Opinion for Conditional Approval in European Union

  July 20, 2012

   · 

  1 min read
• Policy

  Johnson & Johnson Will Pay $2.2 Billion in Risperdal Settlement

  July 20, 2012

   · 

  1 min read